Literature DB >> 21383715

Hugging tight in Huntington's.

Ashu Johri, Rajnish K Chaturvedi, M Flint Beal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21383715     DOI： 10.1038/nm0311-245

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  15 in total

1.  Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation.

Authors:  Rajnish K Chaturvedi; Noel Y Calingasan; Lichuan Yang; Thomas Hennessey; Ashu Johri; M Flint Beal
Journal:  Hum Mol Genet       Date:  2010-06-07       Impact factor: 6.150

2.  Dynasore, a cell-permeable inhibitor of dynamin.

Authors:  Eric Macia; Marcelo Ehrlich; Ramiro Massol; Emmanuel Boucrot; Christian Brunner; Tomas Kirchhausen
Journal:  Dev Cell       Date:  2006-06       Impact factor: 12.270

3.  Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization.

Authors:  Ann Cassidy-Stone; Jerry E Chipuk; Elena Ingerman; Cheng Song; Choong Yoo; Tomomi Kuwana; Mark J Kurth; Jared T Shaw; Jenny E Hinshaw; Douglas R Green; Jodi Nunnari
Journal:  Dev Cell       Date:  2008-02       Impact factor: 12.270

4.  Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.

Authors:  Patrick Weydt; Victor V Pineda; Anne E Torrence; Randell T Libby; Terrence F Satterfield; Eduardo R Lazarowski; Merle L Gilbert; Gregory J Morton; Theodor K Bammler; Andrew D Strand; Libin Cui; Richard P Beyer; Courtney N Easley; Annette C Smith; Dimitri Krainc; Serge Luquet; Ian R Sweet; Michael W Schwartz; Albert R La Spada
Journal:  Cell Metab       Date:  2006-10-19       Impact factor: 27.287

Review 5.  Small molecule inhibitors of mitochondrial division: tools that translate basic biological research into medicine.

Authors:  Laura L Lackner; Jodi Nunnari
Journal:  Chem Biol       Date:  2010-06-25

Review 6.  PGC-1alpha, a new therapeutic target in Huntington's disease?

Authors:  Jetta K McGill; M Flint Beal
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

7.  Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.

Authors:  Jinho Kim; Jennifer P Moody; Christina K Edgerly; Olivia L Bordiuk; Kerry Cormier; Karen Smith; M Flint Beal; Robert J Ferrante
Journal:  Hum Mol Genet       Date:  2010-07-21       Impact factor: 6.150

Review 8.  Mitochondrial structural and functional dynamics in Huntington's disease.

Authors:  P Hemachandra Reddy; Peizhong Mao; Maria Manczak
Journal:  Brain Res Rev       Date:  2009-04-24

Review 9.  The energetics of Huntington's disease.

Authors:  Susan E Browne; M Flint Beal
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

10.  Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli.

Authors:  Veronica Costa; Marta Giacomello; Roman Hudec; Raffaele Lopreiato; Gennady Ermak; Dmitri Lim; Walter Malorni; Kelvin J A Davies; Ernesto Carafoli; Luca Scorrano
Journal:  EMBO Mol Med       Date:  2010-12       Impact factor: 12.137
View more
  5 in total

Review 1.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

Review 2.  Mitochondrial dysfunction in neurodegenerative diseases.

Authors:  Ashu Johri; M Flint Beal
Journal:  J Pharmacol Exp Ther       Date:  2012-06-13       Impact factor: 4.030

Review 3.  Mitochondrial iron metabolism and neurodegenerative diseases.

Authors:  Ruiying Cheng; Varun V Dhorajia; Jonghan Kim; Yuho Kim
Journal:  Neurotoxicology       Date:  2021-11-05       Impact factor: 4.294

Review 4.  PGC-1α, mitochondrial dysfunction, and Huntington's disease.

Authors:  Ashu Johri; Abhishek Chandra; M Flint Beal
Journal:  Free Radic Biol Med       Date:  2013-04-19       Impact factor: 7.376

5.  Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease.

Authors:  Zhiyin Xun; Sulay Rivera-Sánchez; Sylvette Ayala-Peña; James Lim; Helen Budworth; Erin M Skoda; Paul D Robbins; Laura J Niedernhofer; Peter Wipf; Cynthia T McMurray
Journal:  Cell Rep       Date:  2012-11-01       Impact factor: 9.423
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.